Su
Non verificato

Sunflower Therapeutics

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMercato del lavoroSalute
14/04/2026
Mercato del lavoro
Industria
Oncologia
Salute
Vetrine/Shopping
Animali
Sanità
Biotecnologia
Veterinaria
BioTesserae Conducts Milestone First in Dog Studies with Proprietary PD-1 Single Domain Antibody
1.00
03/12/2025
Industria
Tecnica
HIV, AIDS e malattie autoimmuni
Software
Biotecnologia
Hardware informatico
Sanità
Salute
Mercato del lavoro
Sunflower Therapeutics Completes Major Installation of Daisy Petal™ Systems at the Serum Institute of India, the World’s Largest Vaccine Manufacturer
1.00
18/09/2025
Oncologia
Salute
Sanità
Scienza
Farmaceutica
Biotecnologia
Mercato del lavoro
Sunflower Therapeutics Receives First Milestone Payment Through Collaboration with SK bioscience on Cost-Effective HPV Vaccine
1.00
03/09/2025
Industria
Scienza
Tecnica
Attrezzature medico-sanitarie
Biotecnologia
Hardware informatico
Salute
Information Technology
Sunflower Therapeutics Receives NIH SBIR Funding to Develop an Automated, Continuous Cell Disruption Platform for VLP-Based Vaccine Manufacturing
1.00
23/07/2025
Information Technology
Biotecnologia
Tecnica
Industria
Salute
Attrezzature medico-sanitarie
Software
Ingegneria
Hardware informatico
Mercato del lavoro
Sunflower Therapeutics Announces Exclusive Distribution Agreement with Alflow Scandinavia A/S
1.00
30/04/2025
Mercato del lavoro
Industria
Ingegneria
Salute
Sanità
Farmaceutica
Biotecnologia
Sunflower Therapeutics Announces an Exclusive Sales Representation Agreement with Optimal Biotech Group
1.00
26/02/2025
Industria
Tecnica
Biotecnologia
Farmaceutica
Salute
Information Technology
Scienza
Mercato del lavoro
Sunflower Therapeutics Engages PharmNXT Biotech LLP as Distributor for the Daisy Petal™ Perfusion Bioreactor System
1.00
03/12/2024
Scienza
Biotecnologia
Farmaceutica
Ecologia/Salute ambientale
Attrezzature medico-sanitarie
Salute
Sunflower Therapeutics Closes $3M Simple Agreement for Future Equity (SAFE) with Oversubscription
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0